Thu, Apr 17, 2014, 9:37 AM EDT - U.S. Markets close in 6 hrs 23 mins


% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

paleodrome 8 posts  |  Last Activity: Apr 15, 2014 4:42 PM Member since: Nov 10, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Waiting on the Data

    by rxonman Apr 15, 2014 4:00 PM
    paleodrome paleodrome Apr 15, 2014 4:42 PM Flag

    you forget a simple thing: This is a double-blind study. The first thing that people will be told is the fact that they can't be sure if the do in fact get the drops or not. They may be getting the placebo. Also AMD is usually occuring in both eyes. Here they will only treat (or placebo) one eye.
    That will indeed dampen optimism among patients.
    So please be patient. Only the results will matter and they are the only thing having any significance for the stock price. Everything else is pure speculation.

  • I know that this is not funny for longs (including myself).
    A long time ago I came across this rule for investing in stocks and it has served me well:

    When buying a stock, you should feel awful (because it has fallen so much)
    When selling a stock you should feel awful as well (because it has risen so much).

    Interesstingly enough, whenever OHRP is increasing fast (it has done that several times), euphoria breaks out and buying this stock feels great (the stock is rising). But then you missed already a big upturn.
    Selling is the same: Whenever the stock is falling (like now) there are these posters who seem to fall into depression and horrible fits about the end of the world and why is the stock no going up? And consequently sell.

    I am not buying (at this moment) and not selling either. But great profits are made when nobody wants to buy and nobody wants to sell. Today the stock was down but volume was low. That is telling me something.

  • Biotech gets crushed and OHRP is up. All seems just fine and has not changed a bit in the last few days (for longterm longs). This is a highly speculative Micro-Biotech. If you can't take the heat, don't go into the kitchen.
    To me it has never been more attractive to invest in OHRP.

  • This is not funny for longs, I know.
    But stay calm and let the facts govern your trading. NOTHING has changed materially at OHRP.
    This is a big down day with high volume. We know why, read the other posts. OHRP is selling shares for $10.
    That plan was made by OHR a long time ago when the stock was $9. At that time $10 was at a premium and totally industry standard procedure. That's all.
    The catalyst that will determine the fate of this stock is how successful Squalamine is. In my analysis it is either successful or very successful.
    I bought today, it is part of my plan.
    For the more timid: Wait until volume recedes and the stock is not going down anymore. That is showing you that panic selling has ended. Then buy the next day with limit orders. My confidence in this company has not changed a bit.
    Don't buy more than you can afford to lose.
    Just my 2 cents.

  • After several days of severe down movement, I would not be surprised to see OHRP going below 10 again.
    Takes conviction to stay put. When too many party goers run for the exit at the same time you have a day like today. So far it was very easy to make money with this stock. Now, the market is sparating the pros from the amateurs (not claiming I am a pro).
    I won't sell, if it does indeed go under 10 I intend to add a good chunk again. .

  • paleodrome by paleodrome Apr 7, 2014 11:34 AM Flag

    Well, since everybody who is interested in OHRP has already bought the stock, no new buyers are active and the fidgety and weak holders ones are selling. The rest is busy to speculate.
    There is absolutely nothing to say about OHR until results are published. All posts are white noise.

  • We still don't know what was said in the conference?????
    According to the stock movement it couldn't be too exciting.

  • paleodrome by paleodrome Mar 10, 2014 12:47 PM Flag

    I am wondering if the current high volume is a sign of preadators of the like as Pfizer, Regn etc. might be stepping in big time. Especially REGN should be worried as hell as OHR will take away their business in 2 years. For these companies to buy OHR now will be small money. Especially now, as the stock is still cheap.

    In 2 years, even their pockets might not be deep enough.

13.57-0.35(-2.51%)9:37 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.